AD-182

N/A

Report date: 2022/09/01 20:01:19
NME

Base Information

Drug NameAD-182
Drug Alias NameAtomoxetine and an orexin antagonistAD-182
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporter
Therapy Area/IndicationsSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesApnimed Inc
China Registration ClassN/A

Develop Information

Active CompaniesApnimed Inc
Inactive CompaniesN/A
Active IndicationsSleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A